Thomas Kofod
Overview
Explore the profile of Thomas Kofod including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foss-Skiftesvik J, Larsen C, Stoltze U, Kofod T, Hove H, Bogeskov L, et al.
Childs Nerv Syst
. 2024 Jul;
40(11):3655-3671.
PMID: 39060747
Craniosynostosis constitutes one of the most common congenital cranial malformations, affecting approximately 6/10,0000 live births. A genetic etiology has long been known for several forms of syndromic craniosynostosis, including pathogenic...
2.
Nguyen V, Kofod T, Nisja E, Hosseini M, Worsaae N
Oral Surg Oral Med Oral Pathol Oral Radiol
. 2024 Apr;
137(6):573-579.
PMID: 38570274
Objective: To evaluate the effect of arthroplasty using interpositional cartilage allografts in patients with temporomandibular joint (TMJ) arthrosis. Study Design: This retrospective study included patients treated consecutively between 2007 and...
3.
Amin H, Andersen S, Jensen S, Kofod T
Oral Maxillofac Surg
. 2024 Feb;
28(3):1117-1125.
PMID: 38418702
Purpose: Tori and exostoses are considered risk factors for the development of medication-related osteonecrosis of the jaw (MRONJ). The aims of this study were to present the prevalence of MRONJ...
4.
Treatment Effect of Zoledronic Acid in Chronic Non-bacterial Osteomyelitis of the Jaw: A Case Series
Jansen R, Nilsson J, Buch-Larsen K, Kofod T, Schwarz P
Calcif Tissue Int
. 2023 Nov;
114(2):129-136.
PMID: 37991563
Chronic non-bacterial osteomyelitis (CNO) is an autoinflammatory, osteolytic bone disorder sometimes localized to a unifocal site in the jaw, causing long-term pain and reduced function. The aim of this study...
5.
Fogh F, Jensen S, Kofod T, Lauridsen E
Oral Health Prev Dent
. 2023 Feb;
21:33-40.
PMID: 36727836
Purpose: To investigate the survival rate of dental implants in patients diagnosed with osteogenesis imperfecta (OI). Materials And Methods: The study is a retrospective analysis of six individuals (2 males,...
6.
Ottesen C, Andersen S, Jensen S, Kofod T, Gotfredsen K
Clin Exp Dent Res
. 2022 Jul;
8(5):1059-1067.
PMID: 35894761
Objectives: Oral rehabilitation can be a challenge in patients on high-dose antiresorptive medication (HDAR), especially if the alveolar anatomy has changed due to previous medication-related osteonecrosis of the jaw (MRONJ)...
7.
Andersen S, Mogensen D, Schioedt M, Kofod T
Oral Maxillofac Surg
. 2022 Apr;
27(2):251-261.
PMID: 35362853
Purpose: Buccal fat pad (BFP) is used for the closure of large oroantral defects caused by surgical removal of the necrotic bone in patients with medication-related osteonecrosis of the jaw...
8.
Kjaergaard Larsen M, Kofod T, Starch-Jensen T
J Oral Maxillofac Res
. 2022 Feb;
12(4):e2.
PMID: 35222869
Objectives: Cryotherapy is frequently used to diminish postoperative sequelae following mandibular third molar surgery. The objective of this single-blinded randomized controlled trial was to assess the therapeutic efficiency of 30...
9.
Werner Moller Andersen S, Ottesen C, Gotfredsen K, Jensen S, Kofod T, Schiodt M
Oral Maxillofac Surg
. 2022 Jan;
27(1):89-100.
PMID: 35084584
Purpose: Implant placement in patients with cancer receiving high-dose antiresorptive medication (HDAR) is considered contraindicated. This prospective, feasibility study tested the hypothesis that dental implants can be placed in such...
10.
Ottesen C, Schiodt M, Storgaard Jensen S, Kofod T, Gotfredsen K
Oral Surg Oral Med Oral Pathol Oral Radiol
. 2021 Jul;
133(2):165-173.
PMID: 34275774
Objective: Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction to high-dose antiresorptive medication (AR) in patients with cancer. A temporary discontinuation of AR (drug holiday) has been...